Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.

Similar Items

• Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors.
  od: Shih, C K, i dr.
  Izdano: (1991)
• Future of nonnucleoside reverse transcriptase inhibitors
  od: Sluis-Cremer, Nicolas
  Izdano: (2018)
• Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase
  od: Tachedjian, Gilda, i dr.
  Izdano: (2001)
• Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors
  od: Pata, Janice D., i dr.
  Izdano: (2004)
• Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication.
  od: Romero, D L, i dr.
  Izdano: (1991)